Profil Pasien Tinea Korporis di Unit Rawat Jalan Kulit dan Kelamin RSUD Dr. Soetomo Surabaya pada Tahun 2014-2015

Background: The prevalence of dermatophytosis in Indonesia is about 52% of all fungal infection which is dominated by tinea cruris and tinea corporis. The total case of tinea corporis is high, but the information about its risk factor and characteristic is still limited. Objective: This study wa...

Full description

Saved in:
Bibliographic Details
Main Author: Novita Oktaviana, NIM011411131026
Format: Theses and Dissertations NonPeerReviewed
Language:English
English
Published: 2017
Subjects:
Online Access:http://repository.unair.ac.id/67611/1/abstrak.pdf
http://repository.unair.ac.id/67611/2/full%20text.pdf
http://repository.unair.ac.id/67611/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
Description
Summary:Background: The prevalence of dermatophytosis in Indonesia is about 52% of all fungal infection which is dominated by tinea cruris and tinea corporis. The total case of tinea corporis is high, but the information about its risk factor and characteristic is still limited. Objective: This study was undertaken to describe the clinical profile of tinea corporis patients in outpatient clinic of dermatovenereology Dr. Soetomo General Hospital Surabaya. Methods: A retrospective research with cross-sectional method of tinea corporis patients’ medical record at mycology division - outpatient clinic of dermatovenereology of Dr. Soetomo General Hospital Surabaya from 1 January 2014 to 31 December 2015 with 339 samples. Results: Tinea corporis was common in female (58,11%). It was dominated by postpubertal group between fourth and fifth decade of age. Tinea cruris was the most comorbid infection in this case. Based on the laboratory examination, there were 85,25% patients showed positive result for hyphae, 72,57% patients showed negative result for blastospore on KOH test and 64,31% patients showed negative result for Wood’s lamp examination. There were 54,87% patients who had oral griseofulvin as the treatment and 86,30% patients showed the improvement in two weeks from the first treatment.